Ignite Creation Date:
2025-12-25 @ 1:47 AM
Ignite Modification Date:
2025-12-26 @ 3:57 PM
Study NCT ID:
NCT01342094
Status:
COMPLETED
Last Update Posted:
2015-07-10
First Post:
2011-04-24
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
DE-111 Against Timolol Ophthalmic Solution 0.5%
Sponsor:
Santen Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-05
Start Date Type:
None
Primary Completion Date:
2012-09
Primary Completion Date Type:
ACTUAL
Completion Date:
None
Completion Date Type:
None
First Submit Date:
2011-04-24
First Submit QC Date:
None
Study First Post Date:
2011-04-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-04-28
Results First Submit QC Date:
None
Results First Post Date:
2015-05-15
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2015-06-14
Last Update Post Date:
2015-07-10
Last Update Post Date Type:
ESTIMATED